MBOT

$2.76

Post-MarketAs of Mar 17, 8:00 PM UTC

Microbot Medical Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.76
Potential Upside
5%
Whystock Fair Value$2.90
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a cathe...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$185.36M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.23
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-31.87%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
27.32

Recent News

Simply Wall St.
Dec 7, 2025

Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. By way of example, Microbot Medical...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Nov 26, 2025

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index easing 0.1%

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Nov 26, 2025

Sector Update: Health Care Stocks Mixed in Afternoon Trading

Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index up 0.1% and the H

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Oct 29, 2025

Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)

Microbot Medical (MBOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Sep 26, 2025

All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy

Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.